Skip to main content

Announcements

Displaying 73 - 84 of 137 announcements
Diabetes & Endocrinology Workforce Census 2022

Dr. Stella George

We have now launched the annual census of Consultants in Diabetes and Endocrinology. This is being done on behalf of ABCD, SfE, Diabetes UK and The Royal College of Physicians London…

NCEPOD Transition study - young person and parent carer online survey

Dr. Susannah Rowles

  NCEPOD are undertaking a study to look at the process of transition from child to adult health services. As part of this study, they are collecting the views of young people and parent carers…

ABCD publishes the results of the Integrated survey about diabetes services

Dr. Dinesh Nagi

Today, 17th December 2021, ABCD publishes the results of the Integrated survey about diabetes services. https://bjd-abcd.com/index.php/bjd/article/view/781 Please find the link to the raw data of…

Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus

Dr. Hermione Price

As of 25th October 2021, dapagliflozin 5mg is no longer authorised for the treatment of people with type 1 diabetes mellitus (T1DM) and should no longer be used in this population . This is…

The YDEF Marjorie Prize

Dr. Thomas Crabtree

The Young Diabetologist and Endocrinologist Forum committee are very pleased to be able to announce the Marjorie Prize. A little known hero in the discovery of insulin was Marjorie the dog who was…

JBDS enteral feeding forms review - we need your help

Professor Ketan Dhatariya

We are contacting you on behalf of the Joint British Diabetes Societies (JBDS) for inpatient care group. We are currently undertaking a review of our guideline "Glycaemic management during…

Withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes

Dr. Susannah Rowles

ABCD is keen to ensure that all our members are aware of the withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes . Apologies if you've had this update from multiple sources. We…

JBDS needs your help

Professor Ketan Dhatariya

JBDS is updating the ‘Variable rate intravenous insulin infusion (VRIII) for medical inpatients with diabetes’ guideline and we need your help. We need to collect evidence and are asking UK diabetes…

Sanofi Inspired Diabetes Symposium

Professor Mike Baxter

  Join us at the Sanofi Inspired Diabetes Update webinar. An opportunity for a multidisciplinary approach to inform and empower you with knowledge from a diverse range of subjects, impacting on…

Simplifying Insulin Regimens: When, Why, and How to Initiate and Intensify Insulin in Type 2 Diabetes

Dr. Dipesh Patel

Wednesday October 20th 2021, 17:00 – 18:00 BST  Panelists David Strain, MBChB MD FRCP (moderator) Roopa Mehta, MBBS, MRCP Dipesh Patel, BSc, MBBS PhD, MRCP Rene Wong, MD, FRCPC, MEd…

COncise adVice on Inpatient Diabetes (COVID:Diabetes)

Professor Gerry Rayman

  Post COVID-19 diebetes discharge pathway - risk stratification and follow up guidance for people being discharged from secondary care after COVID-19 infection

This is Diabetes Campaign

Dr. Susannah Rowles

ABCD is very supportive of Diabetes UK's "This Is Diabetes Campaign" which  is launching today, the aim of the campaign is to create a connection to people with diabetes - to let them know that…

Looking for something older? Our announcement archive contains announcements older than three years.

photo of announcement author, Dr. Bob Ryder
Dr. Bob Ryder, Consultant Diabetologist,
Members are very much encouraged to take part in our ongoing real world data collection from which we have learned so much (https://abcd.care/all-abcd-audit-publications).In the wake of the…